Amit B. possesses extensive experience in the pharmaceutical and healthcare sectors, having held significant roles at leading companies. At Boehringer Ingelheim from September 2014 to February 2017, Amit B. progressed from Senior Associate Director, Medical Safety to Executive Director, Medical Safety. Subsequent positions included Associate Director of Pharmacovigilance and Clinical Safety Scientist at Novartis from January 2013 to August 2014. Currently, Amit B. serves as Executive Director, Gen Med TA Safety Head at Amgen since September 2024 and recently took on the role of Angel Investor at Pointo from June 2023 to July 2024. Amit B. holds an MBBS from the University College of Medical Sciences, an MBA in Health Care from Vanderbilt University, and a Postgraduate Diploma in Nuclear Medicine from the Institute Of Nuclear Medicine and Allied Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices